Biopharmaceutical company developing therapeutics for orphan genetic diseases with a focus on neuromuscular disorders
- Year invested 2012
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website prosensa.eu/
- Company Status IPO/Acquired (by BioMarin) (NASDAQ: RNA)